Nav: Home

Smoking slowly changes lung cells to increase the odds for cancer

September 11, 2017

Cigarette smoke causes epigenetic changes in lung cells that prime them to develop cancer, and researchers can now observe how these changes unfold over time. Reporting September 11 in the journal Cancer Cell, Johns Hopkins University School of Medicine investigators show that healthy lung cells in a dish exposed to cigarette smoke condensate for 10-15 months--the equivalent of someone smoking 20-30 years--have accumulated epigenetic abnormalities associated with abnormal "turning off" of multiple genes, which are otherwise needed to help protect normal cells from developing cancer.

These changes are accompanied by increased activity of cell signals that would indicate the presence of a mutation in a key oncogene, KRAS; yet no such mutation was present in this or other genes frequently mutated in lung cancer. However, if the investigators inserted a KRAS mutation into the cells with the epigenetic abnormalities, they became cancerous with just this one step and having this one mutation. Introduction of mutant KRAS into healthy cells without chronic exposure to cigarette smoke condensate was not enough to induce tumors.

Studies in The Cancer Genome Atlas and other databases have shown that about 30 % of lung adenocarcinomas, the most frequent type of lung cancer, have KRAS mutations. These tumors also frequently harbor the epigenetic abnormalities produced by the cigarette smoke condensate exposure used in the above lab studies.

"When you're smoking, you are building up a substrate of epigenetic changes that we hypothesize are increasing your mathematics for developing lung cancer, because if you're not a smoker, your risk of lung cancer is very low," says senior author Stephen B. Baylin, co-director of the Cancer Biology program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Hopkins scientist, co-corresponding author Hari Easwaran. "If you are a smoker, however, while you still have 8 or 9 out of 10 chances not to get lung cancer, the mathematics are now still very robustly much more going against you, and maybe it's because there are these epigenetic changes that build up."

Baylin and his colleagues show that lung cells--engineered for these experiments to survive in a laboratory dish in the presence of cigarette smoke condensate--begin to behave abnormally within 10 days of smoke exposure. The first changes are cellular signs of DNA damage and tighter binding to DNA of proteins that help establish the above epigenetic changes. However, only after 10 to 15 months, but not earlier, the DNA is covered in a dramatic number of abnormal methylation marks at the start sites of multiple genes, which is associated with the silencing of the protective genes discussed earlier. DNA methylation is an example of an epigenetic change, as it modifies gene expression rather than altering the basic DNA sequence of the gene.

The researchers identified that the epigenetic changes in the chronically exposed lung cells are responding to smoking by regressing into a more stem-cell like state, meaning that they are priming themselves to self-renew. Mature cells normally repress the types of cell signaling pathways in which KRAS is a key player to help prevent uncontrolled growth. Multiple genes that are silenced with the abnormal epigenetic changes induced by the cigarette smoke exposure would normally act to turn down KRAS signaling.

To test their theory for the role of the epigenetic abnormalities observed, Baylin and his team introduced a single KRAS mutation in lung cells, both exposed and not exposed to cigarette smoke extract, and then transplanted them into mice. The cells exposed for only 6 months did not become cancerous, but, indeed, those exposed for 15 months, which harbored the epigenetic abnormalities, did become cancerous and form lung adenocarcinomas in the mice.

"This work suggests the possibility that unlike mutations, which are harder to reverse, if you stop smoking at a certain time and duration, then you have a chance to decrease your likelihood of getting cancer that might be due to the buildup of epigenetic changes," says first author Michelle Vaz, a postdoctoral researcher at Johns Hopkins University School of Medicine. "The hypothesis is that there are potentially reversible changes that are contributing to a certain set of lung cancers."

Baylin, Easwarn, Vaz, and their collaborators are now exploring the possibility of using therapies that target the specific epigenetic changes that occur in the lung cells of smokers.
-end-
The research was supported by the National Cancer Institute, the National Institutes of Health, and the National Institute of Environmental Health Sciences.

Cancer Cell, Vaz et al: "Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single Step Transformation by KRAS Mutations." http://www.cell.com/cancer-cell/fulltext/S1535-6108(17)30349-5

Cancer Cell (@Cancer_Cell), published by Cell Press, is a monthly journal that provides a high-profile forum to promote major advances in cancer research and oncology. The journal covers topics related to molecular and cellular mechanisms of cancer, mechanisms for the sensitivity and the resistance to cancer therapies, development of better cancer therapies, and clinical investigations. Visit: http://www.cell.com/cancer-cell. To receive Cell Press media alerts, contact press@cell.com.

Cell Press

Related Lung Cancer Articles:

AI helps to fight against lung cancer
Lung cancer has been the leading cause of cancer-related deaths in 2015 in United States.
Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings
The first year of free lung cancer screening in the Augusta, Ga., area found more than double the rate seen in a previous large, national study as well as a Massachusetts-based screening for this No.
Antioxidants and lung cancer risk
An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer.
Lung cancer may go undetected in kidney cancer patients
Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C.
Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Huntsman Cancer Institute research holds promise for personalized lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another.
High levels of estrogen in lung tissue related to lung cancer in postmenopausal women
Researchers from Kumamoto University, Japan have found that postmenopausal women with multicentric adenocarcinoma of the lung have a higher concentration of estrogen in non-cancerous areas of the peripheral lung than similar women diagnosed with single tumor lung cancer.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Pericardial window operation less efficient in cases of lung cancer than any other cancer
Pericardial window operation, a procedure, where abnormal quantity of malignant fluid, surrounding the heart, is drained into the neighbouring chest cavity, is commonly applied to patients diagnosed with cancer.

Related Lung Cancer Reading:

How to Survive Lung Cancer - A Practical 12-Step Plan
by Michael Lloyd (Author)

Written by a lung cancer survivor who understands what it takes to beat the odds, this book offers unparalleled hope and direction for anyone facing this illness. It is filled with specific exercises and techniques to promote healing and reverse side effects by taking a pro-active approach in helping to restore your mind, body and spirit to an optimum state of health. Endorsed by a Lung Cancer Specialist and Associate Professor at Harvard Medical School, this book combines what the doctors tell you with critical information they don't tell you. Visit www.SurviveLungCancer.com for chapter... View Details


Bonnie J. Addario Navigating Lung Cancer 360 Degrees of Hope
by Bonnie J. Addario (Author), MD, PhD, Shane P. Dormady (Author), RN, MSN, CPHQ, Eileen Johnson (Author), RN, MBA, Alicia Sable-Hunt (Author), Danielle Hicks (Editor), MD, Paul Hesketh (Editor), MD, Robert Sinha (Editor), MD, PhD, D. Ross Camidge (Editor), MD, Elizabeth A. David (Editor), MD, Lisa Boohar (Editor), MD, David R. Gandara (Editor), PhD, Guneet Walia (Editor), Inc., Sheila Von Driska?White Space (Editor)

Navigating Lung Cancer 360 Degrees of Hope is the most comprehensive guidebook for surviving lung cancer. Inside each latest edition you will get the most up-to-date navigation tools on the diagnosis process, lung cancer staging, treatment options, clinical trials, living with lung cancer, financing your care, hope for surviving lung cancer, and more. Written by survivor Bonnie J. Addario and the leading experts in lung cancer with one goal: to turn lung cancer into a manageable and survival disease. View Details


100 Questions & Answers About Lung Cancer (100 Questions and Answers)
by Joan H. Schiller (Author), Amy Cipau (Author)

EMPOWER YOURSELF!

No one with lung cancer needs to be alone in their fight against this disease. 100 Questions & Answers About Lung Cancer, Third Edition, guides patients and their families through diagnosis, treatment and survivorship. Providing both the doctor's and patient's point of view, this book is a complete guide to understanding treatment options, post-treatment quality of life, sources of support, and much more. Through 100 Questions & Answers About Lung Cancer, Third Edition, expert authors use their experiences with patients to provide support and hope to the tens of... View Details


The ABCs of Lung Cancer: for Patients and Advocates
by Dusty Joy Donaldson (Author), Kimberly D. Lester (Author), Kimberly D. Lester (Illustrator)

Learn valuable lessons from a longtime lung cancer survivor’s own journey The ABCs of Lung Cancer is a practical, easy-to-read guide for lung cancer patients and the people who care for and about them. Written by an 11-year lung cancer survivor and her daughter, the authors provide useful tips for dealing with and preventing lung cancer, some anecdotes about their own experiences, and, most of all, hope. Structured logically from A–Z, The ABCs of Lung Cancer gives frank advice that is easy to digest, despite the serious topic. Each segment offers insight garnered from the authors’ more... View Details


Lung Cancer: From Diagnosis to Treatment
by Walter Scott MD (Author)

According to the American Cancer Society, nearly 220,000 Americans are diagnosed with lung cancer annually. It accounts for nearly 15 percent of all newly diagnosed cancers. If you've been diagnosed, you probably have many questions about the nature of the disease and your treatment options.Walter J. Scott, M.D., has treated thousands of lung cancer patients who have navigated this overwhelming maze of medical tests and procedures. In Lung Cancer: From Diagnosis to Treatment, Dr. Scott helps you understand the process—from getting a diagnosis to going through treatment. He explains... View Details


Lung Cancer: Your Questions, Expert Answers
by Joan H. Schiller (Author)

EMPOWER YOURSELF!

No one with lung cancer needs to be alone in their fight against this disease. Lung Cancer: Your Questions, Expert Answers, Fourth Edition guides patients and their families through diagnosis, treatment and survivorship. Providing both the doctor's and patient's point of view, this book is a complete guide to understanding treatment options, post-treatment quality of life, sources of support, and much more. Through Lung Cancer: Your Questions, Expert Answers, Fourth Edition, expert authors use their experiences with patients to provide support and hope to the tens of... View Details


You Can Beat Lung Cancer: Using Alternative/Integrative Interventions
by Carl O. Helvie (Author)

Can you overcome lung cancer without harsh chemicals, surgery and debilitation? Are alternative interventions effective? Why do conventional physicians not use them? Can you prevent cancer recurrences and live into old age without chronic diseases and prescribed medications? This book answers these and other questions.

This is one of the most comprehensive books available on alternative treatments for lung cancer. It explains the treatments used successfully by a health professional/cancer survivor of 36 years and by some of the leading medical and health practitioners currently in the... View Details


Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC)
by Harvey I. Pass MD (Editor), David P. Carbone MD PhD (Editor), David H. Johnson MD (Editor), John D. Minna MD (Editor), Giorgio V. Scagliotti MD (Editor), Andrew T. Turrisi III MD (Editor)

Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques.

This edition has expanded thoracic oncology chapters including... View Details


Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)

The revolutionary, New York Times bestselling guide to the powerful lifestyle changes that fight and prevent cancer—an integrative approach based on the latest scientific research
 
“A common-sense blueprint for healthy living.” —Chicago Tribune
 
“Resonating with cancer support communities and recommended nationwide.” —Los Angeles Times
 
“Life affirming . . . filled with practical advice.” —The Seattle Times
 
David Servan-Schreiber was a rising... View Details


Lung Cancer: Myths, Facts, Choices--and Hope
by Claudia I. Henschke (Author), Peggy McCarthy (Author), Sarah Wernick (Contributor)

An authoritative book with new lifesaving strategies for those at risk and those already diagnosed.

Lung cancer kills more women than breast cancer, more men than prostate cancer. This authoritative book presents new lifesaving strategies for those already diagnosed and those at risk (including ex-smokers).

Lung cancer is deadly because it's usually found late. Dr. Claudia Henschke's groundbreaking research on early diagnosis, published in Lancet, made headlines worldwide. Now, for the first time, she offers specific recommendations based on her... View Details

Best Science Podcasts 2017

We have hand picked the best science podcasts for 2017. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Simple Solutions
Sometimes, the best solutions to complex problems are simple. But simple doesn't always mean easy. This hour, TED speakers describe the innovation and hard work that goes into achieving simplicity. Guests include designer Mileha Soneji, chef Sam Kass, sleep researcher Wendy Troxel, public health advocate Myriam Sidibe, and engineer Amos Winter.
Now Playing: Science for the People

#448 Pavlov (Rebroadcast)
This week, we're learning about the life and work of a groundbreaking physiologist whose work on learning and instinct is familiar worldwide, and almost universally misunderstood. We'll spend the hour with Daniel Todes, Ph.D, Professor of History of Medicine at The Johns Hopkins University, discussing his book "Ivan Pavlov: A Russian Life in Science."